Expression System for Recombinant Protein Production
Total Trials
2
As Lead Sponsor
1
As Collaborator
Total Enrollment
93
NCT02647489
Safety and Immunogenicity of the Placental Malaria Vaccine Candidate PAMVAC Variously Adjuvanted
Phase: Phase 1
Role: Collaborator
Start: May 31, 2016
Completion: Nov 10, 2017
NCT06746688
A First-in-human, Clinical Trial Assessing the Safety of ES2B-C001-S01 With or Without [Adjuvant] in Patients With HER2 Expressing Metastatic Breast Cancer.
Role: Lead Sponsor
Start: Jun 3, 2025
Completion: Mar 31, 2026
Loading map...